Dr. Beutler has identified several natural products which have potential for development as cancer drugs, among them, englerins, which are in preclinical development for kidney cancer and Ewing’s sarcoma, schweinfurthins, which are preclinical candidates in glioblastoma and malignant peripheral nerve sheath tumors, and salicylihalamides, of interest in sarcomas. As a Staff Scientist 2, Dr. Beutler oversees the Program's high-throughput screening libraries, information technology, and drug development efforts.
AAAS Fellow
American Association for the Advancement of Science
Others
Molecular Diversity Preservation International
01 May 1998 - present
Senior Scientist or Principal Investigator
National Cancer Institute
01 Apr 1984 - present
Post Doctoral Researcher
University of Texas Medical School, Houston
01 Oct 1983 - 01 Apr 1984
University Educator/Researcher
Auburn University School of Pharmacy
01 Oct 1981 - 01 Jun 1983
Post Doctoral Researcher
Northeastern University Department of Chemistry
01 Sep 1980 - 01 Aug 1981
Graduate Student or Post Graduate
University of the Sciences in Philadelphia
01 Sep 1975 - 01 Jun 1980
Undergraduate Student
Vassar College
01 Sep 1970 - 01 Jun 1972
Undergraduate Student
Lehigh University
01 Sep 1968 - 01 Jun 1970